The Next Big Thing in Healthcare: Precision Cancer Care

Dr. Allen Lai, Regional Managing Director, ACT Genomics Singapore

Venue : Stamford American Auditorium (AmCham Office, 1 Scotts Rd, #23-03 Shaw Centre)

Date : March 08, 2017

Time : 7:45 AM - 9:00 AM

Price : $0.00

Please add to calendar before registering for the event



Obama’s Precision Medicine Initiative in 2015 has shifted healthcare landscape towards personalized healthcare - the principle of strategizing clinical management to the individuals rather than populations. This shift has been prompted by advances in our understanding of disease, improvements in technology and accumulating paradigms of benefit.

However, the shift towards precision medicine requires significant changes in healthcare systems, such as regulatory issues, multi
disciplinary collaboration in a traditionally conservative and siloed health system. There is much opportunity to pioneer the development of precision medicine, particularly in the growing markets of Asia, where there is a dearth of expertise and quality and which many large organizations have as secondary areas of development. In this talk Dr Lai will walk the audience through the evolution of cancer precision medicine and the impact to cancer management, as well as business growth potential in the region.

About the Speaker:

Dr. Allen Lai
Regional Managing Director
ACT Genomics Singapore

Dr. Allen Lai is currently the Regional Managing Director of ACT Genomics Singapore, strategizing corporate development, planning and execution of cancer genomics clinical & research projects in Southeast Asia. He holds several high key profile roles as Advisor Board of ISPOR Asia Consortium, President of ISPOR Singapore and concurrently Senior Consultant, Ministry of Health and Social Welfare, Taiwan. He received his Ph.D. and MPA, from Lee Kuan Yew School of Public Policy, National University of Singapore, M.Sc. (Preventive Medicine) from National Taiwan University and M.D. from Chung Shan Medical Dental University, Taiwan. He was the principal consultant at IMS Health Asia, and the director of Institute of Health Economics & Management and the academic director of MSc Management of Health Industries in ESSEC Business School.

Share on LinkedInShare on FacebookTweet about this on Twitter